Clinical Trial Update: Gene Therapy for Neurofibromatosis Type 2 (NF2) with ST002 [NA]

View source ↗

Summary

A gene therapy trial for neurofibromatosis type 2 using ST002 is currently NOT_YET_RECRUITING, sponsored by the Cancer Institute and Hospital, Chinese Academy o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibromatosis Type

Drugs mentioned

• ST002

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: NF2 Deficiency | NA | Status: NOT_YET_RECRUITING